Medicamen Biotech share news, announcements and annual reports
NSE: MEDICAMEQBSE: 531146Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹256.20.
2 Nov: open ₹254.00, high ₹264.65, low ₹251.10
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹366 Cr1,991st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.38%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,588
Medicamen Biotech share news and announcements
196 announcements, routine notices left out, newest first. Page 4 of 4.
Aug 2022
1 Aug · Board meeting
Jul 2022
Jun 2022
7 Jun · Related Party Transaction
May 2022
25 May · Results
Apr 2022
18 Apr · General updates
12 Apr · Legal
The exchange asked on 6 Apr 2022
Feb 2022
8 Feb · Results
8 Feb · Board meeting
2 Feb · Board meeting
Jan 2022
3 Jan · Business
3 Jan · Trading Plan under PIT
Dec 2021
31 Dec · Business
31 Dec · Trading Plan under PIT
29 Dec · Business
29 Dec · Trading Plan under PIT
21 Dec · Business
21 Dec · Trading Plan under PIT
21 Dec · Business
21 Dec · Trading Plan under PIT
18 Dec · Business
18 Dec · Trading Plan under PIT
18 Dec · Business
18 Dec · Trading Plan under PIT
16 Dec · Business
16 Dec · Trading Plan under PIT
16 Dec · Business
16 Dec · Trading Plan under PIT
16 Dec · Business
16 Dec · Trading Plan under PIT
14 Dec · Business
14 Dec · Trading Plan under PIT
14 Dec · Business
14 Dec · Trading Plan under PIT
10 Dec · Business
10 Dec · Trading Plan under PIT
10 Dec · Business
10 Dec · Trading Plan under PIT
3 Dec · Analysts
Nov 2021
3 Nov · Results